Skip to Main Content
Menu Button
About Us
Our Team
Careers
Technology
Clinical Pipeline
News
Contact
June–July 2024
Brand Icon
Qurgen
successfully produced two GMP-scale batches of the anti-tumor transcription factor protein drug SON-DP. These batches met FDA protein drug quality standards and were supplied to Phase I clinical trials in the U.S. and China.
Recent news & press
2026
Prof Wang was invited to attend Tigermed's ASCO Pre-Event Webinar as a Speaker to introduce...
Learn More
Apr. 2026
no infusion related reaction (IRR) has occurred during the 48-hour continuous infusion by pump, this...
Learn More
